Literature DB >> 26104483

HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: a multicentre retrospective case-control clinical study.

L Cheng1,2, Y Xiong1,2, C Z Qin1,2, W Zhang1,2, X P Chen1,2, J Li3, H H Zhou1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26104483     DOI： 10.1111/bjd.13688

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  10 in total

Review 1.  Recent advances in the understanding of severe cutaneous adverse reactions.

Authors:  N R Adler; A K Aung; E N Ergen; J Trubiano; M S Y Goh; E J Phillips
Journal:  Br J Dermatol       Date:  2017-09-29       Impact factor: 9.302

2.  Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines.

Authors:  Lisanne E N Manson; Jesse J Swen; Henk-Jan Guchelaar
Journal:  Front Pharmacol       Date:  2020-09-23       Impact factor: 5.810

3.  Genotyping HLA-B*5801 for Allopurinol-Induced Severe Cutaneous Adverse Reactions: An Accurate and Prompt Method.

Authors:  Lin Cheng; Lihua Zhang; Lichen Gao; Wei Zhang; Xiaoping Chen; Hong-Hao Zhou
Journal:  Clin Transl Sci       Date:  2015-12-14       Impact factor: 4.689

Review 4.  Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies.

Authors:  Ran Wu; Yi-Ju Cheng; Li-Li Zhu; Lei Yu; Xue-Ke Zhao; Min Jia; Chang-Hui Wen; Xing-Zhen Long; Ting Tang; Ai-Juan He; Yi-Yan Zeng; Zun-Feng Ma; Zhi Zheng; Mu-Zi Ni; Gong-Jing Cai
Journal:  Oncotarget       Date:  2016-12-06

Review 5.  Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Akito Hasegawa; Riichiro Abe
Journal:  F1000Res       Date:  2020-06-16

6.  WGCNA-Based DNA Methylation Profiling Analysis on Allopurinol-Induced Severe Cutaneous Adverse Reactions: A DNA Methylation Signature for Predisposing Drug Hypersensitivity.

Authors:  Lin Cheng; Bao Sun; Yan Xiong; Lei Hu; Lichen Gao; Ji Li; Hongfu Xie; Xiaoping Chen; Wei Zhang; Hong-Hao Zhou
Journal:  J Pers Med       Date:  2022-03-24

7.  PSORS1C1 Hypomethylation Is Associated with Allopurinol-Induced Severe Cutaneous Adverse Reactions during Disease Onset Period: A Multicenter Retrospective Case-Control Clinical Study in Han Chinese.

Authors:  Bao Sun; Lin Cheng; Yan Xiong; Lei Hu; Zhiying Luo; Maosong Zhou; Ji Li; Hongfu Xie; Fazhong He; Xiaoqing Yuan; Xiaoping Chen; Hong-Hao Zhou; Zhaoqian Liu; Xiang Chen; Wei Zhang
Journal:  Front Pharmacol       Date:  2018-01-17       Impact factor: 5.810

8.  The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.

Authors:  Shang-Chen Yang; Sindy Hu; Sheng-Zheng Zhang; Jin-Wen Huang; Jing Zhang; Chao Ji; Bo Cheng
Journal:  J Immunol Res       Date:  2018-02-11       Impact factor: 4.818

9.  Comparison between the HLA-B∗58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions.

Authors:  Niwat Saksit; Nontaya Nakkam; Parinya Konyoung; Usanee Khunarkornsiri; Wongwiwat Tassaneeyakul; Pansu Chumworathayi; Sirimas Kanjanawart; Chonlaphat Sukasem; Alisara Sangviroon; Oranuch Pattanacheewapull; Wichittra Tassaneeyakul
Journal:  J Immunol Res       Date:  2017-12-17       Impact factor: 4.818

10.  Clinical evaluation of a substitute of HLA-B*58:01 in different Chinese ethnic groups.

Authors:  Xinju Zhang; Lei Jin; Zhiyuan Wu; Weizhe Ma; Yuming Chen; Gang Chen; Lixin Wang; Ming Guan
Journal:  Genet Mol Biol       Date:  2018-08-02       Impact factor: 1.771
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.